{"id":"W4408042402","doi":"10.1080/14796694.2025.2459548","title":"CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2– early breast cancer","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Endocrine system; Metastatic breast cancer; Cancer; Gynecology; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001932147,0.001566588,0.00182414,0.000670936,0.0004581694,0.001531519,0.001280817,0.002574118,0.007348483],"category_scores_gemma":[0.001680567,0.0005008006,0.001965459,0.0005573898,0.0008865496,0.001140616,0.0004321808,0.004223925,0.00113411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001015727,"about_ca_system_score_gemma":0.001434592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008179729,"about_ca_topic_score_gemma":0.002642135,"domain_scores_codex":[0.9994621,0.0002821146,0.00002717948,0.00008246642,0.00005346827,0.00009272223],"domain_scores_gemma":[0.9992649,0.0001964486,0.0001771025,0.00005397965,0.00006070994,0.0002467357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8207796,0.02333452,0.001496952,0.003613654,0.001756322,0.0002366778,0.0002022425,0.002089813,0.02040743,0.002363899,0.01406665,0.1096522],"study_design_scores_gemma":[0.8925226,0.09088052,0.001831529,0.0002647404,0.0004699207,0.0002102377,0.00004220306,0.0009200015,0.001717448,0.0009285479,0.01018314,0.00002891612],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8748639,0.06070279,0.003213365,0.006960271,0.001966628,0.01988357,0.007132239,0.0005661661,0.02471104],"genre_scores_gemma":[0.8918677,0.02669254,0.009898424,0.01059567,0.001848341,0.02825728,0.009006496,0.0001699654,0.02166357],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007348483,"threshold_uncertainty_score":0.0245831,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04278605245297019,"score_gpt":0.4233400671943058,"score_spread":0.3805540147413356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}